Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Extension Study to Assess the Long-Term Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension

NCT05968430 is registered in ClinicalTrials.gov with Mineralys Therapeutics Inc. as lead sponsor.

NCT NCT05968430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05968430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Extension Study to Assess the Long-Term Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension
Lead sponsor
Mineralys Therapeutics Inc.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 14, 2023
Completion date
May 31, 2027
Enrollment
1,076 (actual)
Sites
177

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension